Guided Therapeutics, Inc.
GTHP
$0.2655
$0.035515.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.44M | -2.42M | -2.15M | -2.17M | -3.02M |
| Total Depreciation and Amortization | 97.00K | 95.00K | 93.00K | 90.00K | 88.00K |
| Total Amortization of Deferred Charges | 128.00K | 93.00K | 105.00K | 115.00K | 130.00K |
| Total Other Non-Cash Items | 84.00K | 107.00K | -68.00K | 35.00K | 1.12M |
| Change in Net Operating Assets | 783.00K | 1.00M | 898.00K | 811.00K | 341.00K |
| Cash from Operations | -1.35M | -1.12M | -1.12M | -1.12M | -1.35M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 792.00K | 587.00K | 387.00K | 200.00K | -- |
| Total Debt Repaid | -578.00K | -477.00K | -313.00K | -384.00K | -286.00K |
| Issuance of Common Stock | 835.00K | 835.00K | 541.00K | 241.00K | 241.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -29.00K | -29.00K | -29.00K | -17.00K | -- |
| Cash from Financing | 1.02M | 916.00K | 586.00K | 40.00K | -45.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -330.00K | -203.00K | -537.00K | -1.08M | -1.39M |